Induction of pyroptosis in colon cancer cells by LXRβ

Cédric Rébé1, Valentin Derangère2, François Ghiringhelli3

  • 1Institut National de la Santé et de la Recherche Médicale (INSERM); UMR 866; Dijon, France; Centre Georges François Leclerc; Dijon, France.

Insights

Liver X receptors (LXRs) show anticancer potential. LXR-beta specifically triggers pyroptosis, a cell death pathway, in colon cancer cells, suggesting it as a novel therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Mechanisms

Background:

  • Liver X receptors (LXRs) are nuclear receptors implicated in cholesterol and lipid metabolism.
  • Emerging evidence suggests LXRs possess anticancer properties, although their precise roles are still under investigation.
  • A non-genomic function of LXR-beta in cancer has been recently identified.

Purpose of the Study:

  • To investigate the role of Liver X receptor beta (LXRβ) in colon cancer.
  • To explore the potential of LXRβ as a therapeutic target for colon cancer treatment.

Main Methods:

  • Treatment of colon cancer cells with LXR agonists.
  • In vitro and in vivo studies to assess cell death.
  • Analysis of LXRβ's non-genomic signaling pathways.

Main Results:

  • LXRβ activation by agonists induces pyroptosis in colon cancer cells.
  • This effect was observed both in vitro and in vivo.
  • LXRβ plays a direct role in promoting cancer cell death.

Conclusions:

  • LXRβ mediates a non-genomic anticancer effect in colon cancer.
  • Targeting LXRβ could be a viable strategy for colon cancer therapy.
  • Pyroptosis induction by LXRβ presents a novel therapeutic avenue.

Related Concept Videos